b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">28980872</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>07</Month>\n            <Day>01</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>07</Month>\n            <Day>01</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1551-4005</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>16</Volume>\n                    <Issue>24</Issue>\n                    <PubDate>\n                        <Year>2017</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Cell cycle (Georgetown, Tex.)</Title>\n                <ISOAbbreviation>Cell Cycle</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>2396-2403</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1080/15384101.2017.1387699</ELocationID>\n            <Abstract>\n                <AbstractText>Arsenic trioxide (ATO) has been reported to exert its anti-cancer activities in human cancers. However, the molecular mechanism of ATO-triggered anti-tumor activity has not been fully elucidated. Recently, multiple studies demonstrated that ATO could regulate miRNAs in human cancers. Therefore, in this study, we investigated whether ATO regulated let-7a in breast cancer cells. We found that ATO upregulated let-7a level in breast cancer cells. We also found that up-regulation of let-7a inhibited cell growth and induced apoptosis and retarded cell migration and invasion. We also observed that up-regulation of let-7a enhanced cell growth inhibition and invasion suppression induced by ATO treatment. Our findings suggest that ATO suppressed cell growth, stimulated apoptosis, and retarded cell invasion partly via upregulation of let-7a in breast cancer cells. Our study provides a new anti-tumor mechanism of ATO treatment in breast cancer.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Shi</LastName>\n                    <ForeName>Ying</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cao</LastName>\n                    <ForeName>Tong</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>b Research Center of Clinical Laboratory Science , Bengbu Medical College , Bengbu , Anhui , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Huang</LastName>\n                    <ForeName>Hua</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lian</LastName>\n                    <ForeName>Chaoqun</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yang</LastName>\n                    <ForeName>Ying</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Zhiwei</ForeName>\n                    <Initials>Z</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>c Department of Pathology , Beth Israel Deaconess Medical Center , Harvard Medical School , Boston , MA , USA.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>d The Cyrus Tang Hematology Center and Collaborative Innovation Center of Hematology , Soochow University , Suzhou , Jiangsu , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ma</LastName>\n                    <ForeName>Jia</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Xia</LastName>\n                    <ForeName>Jun</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Department of Biochemistry and Molecular Biology , Bengbu Medical College, Bengbu , Anhui , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>20</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Cell Cycle</MedlineTA>\n            <NlmUniqueID>101137841</NlmUniqueID>\n            <ISSNLinking>1551-4005</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C487931">mirnlet7 microRNA, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>S7V92P67HO</RegistryNumber>\n                <NameOfSubstance UI="D000077237">Arsenic Trioxide</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077237" MajorTopicYN="N">Arsenic Trioxide</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Arsenic trioxide</Keyword>\n            <Keyword MajorTopicYN="Y">Let-7a</Keyword>\n            <Keyword MajorTopicYN="Y">apoptosis</Keyword>\n            <Keyword MajorTopicYN="Y">breast cancer</Keyword>\n            <Keyword MajorTopicYN="Y">cell growth</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>6</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>2</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>6</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">28980872</ArticleId>\n            <ArticleId IdType="doi">10.1080/15384101.2017.1387699</ArticleId>\n            <ArticleId IdType="pmc">PMC5788432</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>PLoS One. 2013 Dec 31;8(12):e85995</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24392034</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2015 Jul 28;10(7):e0133643</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26218285</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Anticancer Agents Med Chem. 2015;16(2):247-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26118712</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Asian Pac J Cancer Prev. 2015 ;16(13):5191-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26225652</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tumour Biol. 2017 Feb;39(2):1010428317692255</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28218039</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 May 16;8(20):32550-32565</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28427227</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Cycle. 2015;14(11):1686-97</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25955298</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2011 Aug 05;11(9):644-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21822212</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Physiol Biochem. 2013;32(6):1818-29</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24356076</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Drug Targets. 2012 Dec;13(14):1750-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23140286</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neoplasma. 2013;60(3):247-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23373993</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Life Sci. 2016 Apr 15;151:30-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26924493</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell Int. 2013 Mar 13;13(1):25</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23497375</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2015 Oct 20;6(32):32944-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26460550</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res. 2012 Jan 18;14(1):R14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22251626</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Res. 2017 Mar;15(3):340-347</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28031413</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CA Cancer J Clin. 2017 Jan;67(1):7-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28055103</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Surg Oncol. 2014 Dec;21 Suppl 4:S687-95</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25047463</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Feb 14;8(7):11206-11218</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28061438</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Med Rep. 2015 Jul;12 (1):1233-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25824027</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2015 Feb 10;6(4):2451-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25669981</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2013 Dec 11;8(12):e83083</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24349438</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Asian Pac J Cancer Prev. 2016;17 (4):1887-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27221871</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2010 Jun 1;292(1):64-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19962820</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tumour Biol. 2016 May;37(5):5919-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26592252</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Onco Targets Ther. 2017 Mar 14;10 :1585-1601</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28352191</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicol Lett. 2013 Jun 20;220(1):61-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23542114</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicol Lett. 2014 Jun 5;227(2):75-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24680928</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Drug Targets. 2013 Sep;14 (10 ):1150-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23834147</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Neuropathol Commun. 2014 Mar 31;2:31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24685274</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Prev Res (Phila). 2012 Mar;5(3):355-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22086681</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2015 Jan 30;6(3):1740-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25638153</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Biother Radiopharm. 2012 Oct;27(8):504-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22988968</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2012 Jan 1;72 (1):335-45</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22108826</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Mol Neurosci. 2015 Apr;55(4):985-94</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25355491</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2011 Nov 24;11(12):849-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22113163</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Cancer Drug Targets. 2014;14 (6):557-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25088040</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Carcinog. 2015 Sep;54(9):859-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24729530</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicol Lett. 2014 Nov 18;231(1):55-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25196641</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomed Pharmacother. 2016 Mar;78:301-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26898455</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Ther Med. 2011 May;2(3):481-486</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22977528</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Sci. 2014 Dec;105(12):1541-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25283513</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2006 Nov;6(11):857-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17060945</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Contemp Oncol (Pozn). 2015;19(2):108-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26034387</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Oncol. 2015;46(6):2526-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25846193</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Pharm Des. 2014;20(33):5354-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24479808</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Surg. 2010 Mar;251(3):499-505</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20134314</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Oncol. 2014 Jan;44(1):229-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24172884</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Oncol. 2015 Feb;46(2):841-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25405645</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2011 Aug 1;307(1):26-36</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21463919</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2015 Feb 20;6(5):3268-79</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25605244</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Jul 25;8(30):49144-49155</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28467781</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Biophys Res Commun. 2016 Jan 1;469(1):55-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26592661</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'